206 related articles for article (PubMed ID: 16734513)
1. Immunization therapy in Alzheimer's disease.
Mor F; Monsonego A
Expert Rev Neurother; 2006 May; 6(5):653-9. PubMed ID: 16734513
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy as treatment for Alzheimer's disease.
Hawkes CA; McLaurin J
Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
[TBL] [Abstract][Full Text] [Related]
4. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
Foster JK; Verdile G; Bates KA; Martins RN
Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
[TBL] [Abstract][Full Text] [Related]
5. [Perspectives in immunotherapy of Alzheimer's disease].
Rossi G
Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235
[TBL] [Abstract][Full Text] [Related]
6. Current progress in beta-amyloid immunotherapy.
Schenk D; Hagen M; Seubert P
Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
Solomon B
Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
[TBL] [Abstract][Full Text] [Related]
8. The immune system, amyloid-beta peptide, and Alzheimer's disease.
Weksler ME; Gouras G; Relkin NR; Szabo P
Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in Alzheimer's disease: where do we stand? Where should we go?
von Bernhardi R
J Alzheimers Dis; 2010; 19(2):405-21. PubMed ID: 20110590
[TBL] [Abstract][Full Text] [Related]
10. [Novel vaccine therapy for Alzheimer's disease--recent progress and our approach].
Okura Y; Matsumoto Y
Brain Nerve; 2008 Aug; 60(8):931-40. PubMed ID: 18717197
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic approaches to Alzheimer's disease.
Monsonego A; Weiner HL
Science; 2003 Oct; 302(5646):834-8. PubMed ID: 14593170
[TBL] [Abstract][Full Text] [Related]
12. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM
J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213
[TBL] [Abstract][Full Text] [Related]
13. [Current trend of immunotherapy for Alzheimer's disease].
Matsumoto SE; Tabira T
Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta immunotherapies in mice and men.
Brendza RP; Holtzman DM
Alzheimer Dis Assoc Disord; 2006; 20(2):118-23. PubMed ID: 16772748
[TBL] [Abstract][Full Text] [Related]
15. Immunology and immunotherapy of Alzheimer's disease.
Weiner HL; Frenkel D
Nat Rev Immunol; 2006 May; 6(5):404-16. PubMed ID: 16639431
[TBL] [Abstract][Full Text] [Related]
16. Anti-amyloid antibody drugs in clinical testing for Alzheimer's disease.
Bednar MM
IDrugs; 2009 Sep; 12(9):566-75. PubMed ID: 19697276
[TBL] [Abstract][Full Text] [Related]
17. Call for Elan to publish Alzheimer's trial details.
Bishop GM; Robinson SR; Smith MA; Perry G; Atwood CS
Nature; 2002 Apr; 416(6882):677. PubMed ID: 11961526
[No Abstract] [Full Text] [Related]
18. Antibody therapy for Alzheimer's disease.
Morgan D
Expert Rev Vaccines; 2003 Feb; 2(1):53-9. PubMed ID: 12901597
[TBL] [Abstract][Full Text] [Related]
19. Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety.
Okura Y; Miyakoshi A; Kohyama K; Park IK; Staufenbiel M; Matsumoto Y
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9619-24. PubMed ID: 16769900
[TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid immunisation in Alzheimer's disease.
Sorbi S
Neurol Sci; 2005 May; 26 Suppl 1():S5. PubMed ID: 15883696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
